1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78. PMID:
11857671
2. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011;108:1132-8. PMID:
21231991
4. Zumrutbas AE, Bozkurt AI, Tas E, Acar CI, Alkis O, Coban K, et al. Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey. Int J Urol 2014;21:1027-33. PMID:
24931070
5. Chung JH, Kim SA, Choi BY, Lee HS, Lee WS, Kim YT, et al. The association between overactive bladder and fibromyalgia syndrome: a community survey. Neurourol Urody 2013;32:66-9.
6. Son YJ, Kwon BE. Overactive bladder is a distrees in heart failure. Int. Neurourol J 2018;22:77-82.
7. Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, et al. Rsik factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int 2009;103(Suppl 3):24.
8. Coyne KS, Cash B, Kopp Z, Gelhorn H, Milsom L, Berriman S, et al. The prevalence of chronic constipations and faecal incontinence among men and women with symptoms of overactive bladder. BJU Int 2001;107:254-61.
10. Ramos ML, Garcia-Cabo C, Leira R, Dominguez C, Pozo-Rosich P, Vila C, et al. Comorbidity between idiopathic overactive bladder and chronic migraine. Cephalalgia 2018;38:581-4. PMID:
28114808
11. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1-211.
12. Acquadro C, Kopp Z, Coyne KS, Corcos J, Tubaro A, Choo MS, et al. Translating overactive bladder questionnaires in 14 languages. Urology 2006;67:536-40. PMID:
16527574
13. Tarcan T, Mangır N, Özgür MÖ, Akbal C. AOB-V8 aşırı aktif mesane sorgulama formu validasyon çalışması. Üroloji Bülteni 2012;21:113-6.
14. Breslau N, Rasmussen K. The impact of migraine. Epidemiology, risk factors and co-morbidities. Neurology 2001;56:4-12. PMID:
11148226
15. Zarifoglu M, Siva A, Hayran O. The Turkish headache epidemiology study group. An epidemiological study of headache in Turkey: a nationwide survey. Neurology 1998;50(Suppl 4):80-5.
16. Pavlovic JM, Akcali D, Bolay H, Bernstein C, Maleki N. Sex-related influences in migraine. J Neurosci Res 2017;95:587-93. PMID:
27870430
20. Rapp DE, Turk KW, Bales GT, Cook SP. Botulinum toxin type a inhibits calcitonin gene-related peptide from isolated rat bladder. J Urol 2006;175:1138-42. PMID:
16469640
21. Cernuda-Morollon E, Ramon C, Martınez-Camblor P, SerranoPertierra E, Larrosa D, Pascual J. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 2015;156:820-4. PMID:
25735000